MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41434-025-00577-y

Медицинская библиотека · Gene therapy · 2025

AAV-mediated BDNF and GAS6 muscle delivery delays disease onset in SOD1G93A ALS mice.

Le Yicong, Liu Gongjie, Wu Shenzhe, Nissenbaum Marialaina, Kusnecov Alexander W, Furmanski Philip, Birge Raymond B, Zhou Renping

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, with limited treatments. Gene therapy offers an alternative strategy for treating a large portion of ALS patients, however, the disparate genetic alterations in ALS complicate the development of gene therapies. Tyrosine receptor kinase B (TRKB) and Tyro3 receptors are highly expressed in mouse spinal cord motor neurons, suggesting that their ligands, brain-derived neurotrophic factor (BDNF) and growth arrest-specific 6 (GAS6), respectively, are crucial for neuronal survival. In this study, we tested whether genetically induced and muscle tissue-specific expression of such survival-enhancing ligands would ameliorate symptom development in the SOD1G93A ALS mouse model. The therapeutic vectors (AAV-Pmus7-HuBDNF-teLuc or AAV-Pmus7-HuGAS6), or a control vector (AAV-Pmus7-teLuc) were injected intravenously via the retro-orbital route and intramuscularly into the hindlimb skeletal muscle of six-week-old mice. Treatment with the therapeutic vectors delayed disease onset and slowed progression in both male and female mice. Interestingly, a sex-specific response was observed, with female mice benefiting more from the treatments than males. Lumbar motor neuron survival was more sustained in the therapeutic vector-treated group compared to control vector group. No statistically significant extension of lifespan was observed in the treated groups.

Для цитирования: Le Yicong, Liu Gongjie, Wu Shenzhe, Nissenbaum Marialaina, Kusnecov Alexander W, Furmanski Philip, Birge Raymond B, Zhou Renping. AAV-mediated BDNF and GAS6 muscle delivery delays disease onset in SOD1G93A ALS mice.. Gene therapy. 2025. DOI: 10.1038/s41434-025-00577-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.